Nephro Care P/B Ratio
Current P/B Ratio
2.54
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Nephro Care P/B ratio. Nephro Care (NEPHROCARE) P/B ratio is 2.54 (Moderate), book value per share ₹33.53 vs Healthcare average P/B of -0.3 — High - Premium to book value, growth expectations or asset-light model. Browse Nephro Care annual reports for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
P/B Ratio
2.54
Current Price
₹
Book Value/Share
₹33.53
Exchange
None
Book Value Breakdown (2026)
Balance Sheet Components
Total Equity
₹57 Cr
Share Capital
₹17 Cr
Reserves & Surplus
₹40 Cr
Outstanding Shares
17,000,000
Book Value per Share
₹33.53
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
-0.3
Sector Median
0.39
Sector Rank
#11 of 50
Sector Percentile
22.0%
NEPHROCARE P/B Ratio — Valuation Insights & Book Value Analysis
Nephro Care price-to-book ratio interpretation, valuation status and historical context — current P/B 2.54 (Moderate). Read NEPHROCARE ex-dividend dates for the complete payout history and dividend yield track record.
- Trading at premium to sector average PB of -0.3
NEPHROCARE vs Healthcare Peers — P/B Ratio Comparison
Nephro Care P/B 2.54 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |